THORACIC SURGERY / CLINICAL RESEARCH
Long-term follow-up results of patients diagnosed with nonspecific pleuritis by video-assisted thoracoscopic surgery biopsy
More details
Hide details
1
Department of Pulmonology, University of Health Sciences Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey
2
Department of Pulmonology, Canakkale State Hospital, Canakkale, Turkey
3
Department of Pathology, University of Health Sciences Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey
4
Department of Thoracic Surgery, University of Health Sciences Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey
5
Department of Thoracic Surgery, Canakkale State Hospital, Canakkale, Turkey
Submission date: 2020-06-09
Final revision date: 2020-09-17
Acceptance date: 2020-09-19
Online publication date: 2020-10-23
Publication date: 2026-08-28
Corresponding author
Meltem Agca
Department of Pulmonology
University of Health Sciences
Sureyyapasa Chest Diseases and Thoracic Surgery Training Hospital
Istanbul, Turkey
Arch Med Sci 2026;22(4):2114-2122
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Non-specific pleuritis (NSP) is a fibrinous or inflammatory pleurisy that is not attributable to a benign or malign etiology. The long-term follow-up results of patients diagnosed with NSP following video-assisted thoracoscopic surgery (VATS) were investigated in this study.
Material and methods:
This investigation focused on 593 patients with exudative pleural effusion who underwent VATS between 2011 and 2014. Of the 137 patients diagnosed with NSP, a total of 39 patients were excluded from the study.
Results:
Out of the 98 patients, 78 were male (80%) with their mean age being 52.2 ±15.9 years. The mean follow-up period was 1919 ±744 days. Of these patients, 70 (71.4%) had no specific diagnosis, while 28 patients (28.6%) did have specific diagnoses. Malignancy was detected in seven (7.1%) of those with specific diagnoses, with most of the diagnoses of malignancy detected within the first 36 months. Malignant diseases included mesothelioma (n = 2), lung cancer (n = 2), chronic lymphocytic leukemia (n = 1), soft tissue sarcoma (n = 1), and multiple myeloma (n = 1). Chest radiographs of malignant patients showed that statistically significantly larger amounts of fluid (40% vs. 6.9%, p = 0.026), pleural plaque (20% vs. 1.1%, p = 0.020) and nodules (20% vs. 7.7%, p = 0.020) were detected compared to patients with a benign course.
Conclusions:
Most patients diagnosed with NSP after VATS had a benign disease course. There was a probability of malignancy, although it was low. Mesothelioma and other malignancies could be seen within the first 36 months after the biopsy. Apart from mesothelioma, other malignancies should also be considered, and further follow-up recommended for patients with a large amount of fluid, plaque and nodules found in the initial VATS images.
REFERENCES (34)
1.
Hooper C, Lee YC, Maskell N. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65: ii4-17.
2.
Light RW, Lee YCG (eds.). Textbook of Pleural Diseases. Boca Raton: CRC Press, Taylor and Francis Group; 2016.
3.
Fishman AP, Elias JA, Fishman JA, Grippi MA, Senlor RM, Pack AI (eds.). Fishman’s Pulmonary Diseases and Disorders. New York: Mc Graw-Hill Education; 2008.
4.
Light RW, Rogers JT, Moyers JP, et al. Prevalence and clinical course of pleural effusions at 30 days after coronary artery and cardiac surgery. Am J Respir Crit Care Med 2002; 166: 1567-71.
5.
Maskell NA. Undiagnosed pleural effusions. In: Light RW, Gary Lee YC (eds.). Textbook of Pleural Diseases. 2th ed. London: CRC Press, Taylor and Francis Group; 2008, pp. 491-8.
6.
Boutin C, Viallat JR, Cargnino P, Farisse P. Thoracoscopy in malignant pleural effusions. Am Rev Resp Dis 1981; 124: 588-92.
7.
Shojaee S, Lee HJ. Thoracoscopy: medical versus surgical – in the management of pleural diseases. J Thorac Dis 2015; 7: 339-51.
8.
Medford AR, Awan YM, Marchbank A, Rahamim J, Unsworth-White J, Pearson PJ. Diagnostic and therapeutic performance of video-assisted thoracoscopic surgery (VATS) in investigation and management of pleural exudates. Ann R Coll Surg Engl 2008; 90: 597-600.
9.
Hazelrigg SR, Nunchuck SK, LoCicero J 3rd. Video assisted thoracic surgery study group data. Ann Thorac Surg 1993; 56: 1039-43.
10.
Salm SA. The pleura. Am Rev Respir Dis 1988; 138: 184-234.
11.
Janssen J, Maldonado F, Metintas M. What is the significance of non-specific pleuritis? A trick question. Clin Respir J 2018; 12: 2407-10.
12.
Yang T, Wu YB, Wang Z, et al. Long-term outcome of patients with nonspecific pleurisy at medical thoracoscopy. Respir Med 2017; 124: 1-5.
13.
Janssen JP, Ramlal S, Mravunac M. The long-term follow- up of exudative pleural effusion after nondiagnostic thoracoscopy. J Bronchol 2004; 11: 169-74.
14.
Davies HE, Nicholson JE, Rahman NM, Wilkinson EM, Davies RJ, Lee YC. Outcome of patients with nonspecific pleuritis/fibrosis on thoracoscopic pleural biopsies. Eur J Cardiothorac Surg 2010; 38: 472-7.
15.
DePew ZS, Verma A, Wigle D, Mullon JJ, Nichols FC, Maldonado F. Nonspecific pleuritis: optimal duration of follow-up. Ann Thorac Surg 2014; 97: 1867-71.
16.
Ferrer JS, Muñoz XG, Orriols RM, Light RW, Morell FB. Evolution of idio-pathic pleural effusion: a prospective, long-term follow-up study. Chest 1996; 109: 1508-13.
17.
Ryan CJ, Rodgers RF, Unni KK, Hepper NG. The outcome of patients with pleural effusion of indeterminate cause at thoracotomy. Mayo Clin Proc 1981; 56: 145-49.
18.
Karpathiou G, Anevlavis S, Tiffet O, et al. Clinical long-term outcome of non-specific pleuritis (NSP) after surgical or medical thoracoscopy. J Thorac Dis 2020; 12: 2096-104.
19.
Metintas M, Ak G, Cadirci O, Yildirim H, Dundar E, Metintas S. Outcome of patients with fibrinous pleuritis after medical thoracoscopy. Respir Med 2012; 106: 1177-83.
20.
Akl Y, Kaddah S, Abdelhafeez A, Salah R, Lotayef M. Epidemiology of mesothelioma in Egypt. A ten-year (1998-2007) multicentre study. Arch Med Sci 2010; 6: 926-31.
21.
Leslie WK, Kinasewitz CT. Clinical characteristics of the patients with nonspecific pleuritis. Chest 1988; 94: 603-8.
22.
Kim NJ, Hong SC, Kim JO, Suhr JW, Kim SY, Ro HK. Etiologic considerations of nonspecific pleuritis. Korean. J Intern Med 1991; 6: 58-63.
23.
Venekamp LN, Velkeniers B, Noppen M. Does ‘idiopathic pleuritis’ exist? Natural history of non-specific pleuritis diagnosed after thoracoscopy. Respiration 2005; 72: 74-8.
24.
Cagle PT, Allen TC. Pathology of the pleura: what the pulmonologists need toknow. Respirology 2011; 16: 430-8.
25.
Al-Izzi M, Thurlow NP, Corrin B. Pleural mesothelioma of connective tissue type, localized fibrous tumour of the pleura, and reactive submesothelial hyperplasia. An immunohistochemical comparison. J Pathol 1989; 158: 41-4.
26.
Coppola A, Ghinassi G, Ciarleglio G, et al. Pleural effusion as first extra-medullary clinical presentation of an occult multiple myeloma: the role of medical thoracoscopy. Respir Med Case Rep 2020; 29: 101013.
27.
Ahmed S, Siddiqui AK, Rossoff L, Sison CP, Rai KR. Pulmonary complications in chronic lymphocytic leukemia. Cancer 2003; 98: 1912-7.
28.
Chen AL, Janko E, Pitman MB, Chebib I. Clinical, cytologic, and immunohistochemical features of sarcomas involving body cavity fluids. Cancer Cytopathol 2019; 127: 778-84.
29.
Maskell NA, Butland RJ. BTS guidelines for the investigation of a unilateral pleural effusion in adults. Thorax 2003; 58: ii8-17.
30.
Gunluoglu G, Olcmen A, Gunluoglu MZ, et al. Long-term outcome of patients with undiagnosed pleural effusion. Arch Bronconeumol 2015; 51: 632-6.
31.
Janssen JP. Why you do or do not need thoracoscopy. Eur Respir Rev 2010; 19: 213-6.
32.
Wrightson JM, Davies HE. Outcome of patients with nonspecific pleuritis at thoracoscopy. Curr Opin Pulm Med 2011; 17: 242-6.
33.
Shaw M, Collins BF, Ho LA, Raghu G. Rheumatoid arthritis- associated lung disease. Eur Respir Rev 2015; 24: 1-16.
34.
Gaensler EA. ‘Idiopathic’ pleural effusion. N Engl J Med 1970; 283: 816-7.